You are here

  • Home
  • Archive
  • Volume 12, Issue 3
  • Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy

 

Online download statistics by month:

Online download statistics by month: March 2024 to January 2026

AbstractFullPdf
Mar 2024718734348
Apr 2024324325150
May 2024230236134
Jun 202419019382
Jul 202421421484
Aug 202411011066
Sep 202412913070
Oct 202414214267
Nov 202413413659
Dec 202413813971
Jan 202512612794
Feb 202521121475
Mar 2025156156106
Apr 2025144148100
May 2025172175113
Jun 202510510864
Jul 2025110
Jan 2026001
Total324432881684